Facial nerve repair utilizing intraoperative repair strategies by Brown, Brandon L. et al.
OR I G I N A L R E S E A R CH
Facial nerve repair utilizing intraoperative repair strategies
Brandon L. Brown MS1,2 | Morgan M. Sandelski BS1 | Sarah M. Drejet MD3 |
Elizabeth M. Runge PhD1 | Taha Z. Shipchandler MD3 | Kathryn J. Jones PhD1,4 |
Chandler L. Walker PhD1,4,5
1Department of Anatomy, Cell Biology and
Physiology, Indiana University School of
Medicine, Indianapolis, Indiana
2Department of Anatomical Sciences and
Neurobiology, University of Louisville,
Louisville, Kentucky
3Department of Otolaryngology, Indiana
University School of Medicine, Indianapolis,
Indiana
4Research and Development Service, Richard L
Roudebush Veterans Affairs Medical Center,
Indianapolis, Indiana
5Department of Biomedical Sciences and
Comprehensive Care, Indiana University
School of Dentistry, Indianapolis, Indiana
Correspondence
Chandler L. Walker, Department of Biomedical
Sciences and Comprehensive Care, Indiana
University School of Dentistry, 1121
W. Michigan Street Room 260A, Indianapolis,
IN 46202.
Email: chalwalk@iu.edu
Funding information
U.S. Department of Veterans Affairs
Roudebush VA IMMR Young Investigator
Award and Career Development Award,
Grant/Award Number: IK2RX002688 (C.L.W);
Indiana University Collaborative Research
Grant (K.J.J)
Abstract
Objectives: To determine whether functional and anatomical outcomes following
suture neurorrhaphy are improved by the addition of electrical stimulation with or
without the addition of polyethylene glycol (PEG).
Methods: In a rat model of facial nerve injury, complete facial nerve tran-
section and repair was performed via (a) suture neurorrhaphy alone, (b) neu-
rorrhaphy with the addition of brief (30 minutes) intraoperative electrical
stimulation, or (c) neurorrhaphy with the addition electrical stimulation and PEG.
Functional recovery was assessed weekly for 16 weeks. At 16 weeks postopera-
tively, motoneuron survival, amount of regrowth, and specificity of regrowth were
assessed by branch labeling and tissue analysis.
Results: The addition of brief intraoperative electrical stimulation improved all func-
tional outcomes compared to suturing alone. The addition of PEG to electrical stimu-
lation impaired this benefit. Motoneuron survival, amount of regrowth, and
specificity of regrowth were unaltered at 16 weeks postoperative in all treatment
groups.
Conclusion: The addition of brief intraoperative electrical stimulation to neu-
rorrhaphy in this rodent model shows promising neurological benefit in the surgical
repair of facial nerve injury.
Level of Evidence: Animal study.
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1 | INTRODUCTION
Despite the regenerative ability of the peripheral nervous system
following injury, complete functional recovery remains elusive. In
an effort to improve recovery following facial nerve repair, various
strategies, including artificial nerve conduits, stem cell treatments,
and delivery of neurotrophic factors, have been employed.1-3 These
strategies aim to improve the number of axons crossing the injury site
and improve specificity of regrowth. A major limitation to improving
these outcomes is the disruption of the myotopic organization at
multiple levels in the central nervous system, which contributes to
facial synkinesis.4-6
The addition of electrical stimulation (e.stim) to neurorrhaphy
has improved functional outcomes and the amount and specificity
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of regrowth in multiple models of peripheral nerve injury.7-9 This results
from the ability of e.stim to upregulate expression of pro-regenerative
neurotrophic factors, growth promotion, and myelination genes; aiding
to accelerate axon regrowth.7,10-12 Following facial nerve crush in
the rat, a single, 30-minute session of e.stim improves functional
outcomes.13,14 Due to its translational potential, we use the same,
30-minute intraoperative e.stim protocol in the current study.
In addition to neurorrhaphy, intraoperative treatment utilizing a
fusogen, polyethylene glycol (PEG), has been investigated.15,16 The
PEG treatment protocol developed and characterized by Bittner
et al17 has shown great promise in a rat sciatic nerve injury model,
and our laboratory has previously used this protocol in a rat facial
nerve injury model.18 This protocol first bathes the cut ends of the
nerve in a hypotonic calcium-free solution, followed by application of
an antioxidant, 1% methylene blue (MB) in ddH2O. After microsuture
neurorrhaphy, 50% PEG by weight in sterile water is applied to the
coaptation site, causing nonspecific fusing of neuronal membranes.
Finally, the site is bathed in calcium containing isotonic solution to
seal neuronal membranes not previously fused by PEG. This well char-
acterized protocol has ≥98% success rate when these solutions are
applied in the correct order.19 Successive application of these solutions
prevents sealing of the nerve endings by expelling vesicles, slows the
initiation of injury signaling cascades via inhibiting calcium influx, and
potentially lowers the activation energy of membrane fusion by remov-
ing the hydration barrier surrounding the axolemma.15,20 All of which
are thought to “prime” the axotomized nerve for fusion potentially
restoring some continuity.
We previously evaluated the addition of PEG to neurorrhaphy
following facial nerve transection in the rat, and found it provided no
functional or anatomical benefits beyond suturing alone.18 However,
other combinatorial treatments have been beneficial.8,14,21 Thus, we
hypothesized that the addition of brief intraoperative e.stim to neu-
rorrhaphy would improve functional and anatomical outcomes, and
the combination of e.stim and PEG would further improve outcomes.
To test these hypotheses, functional and anatomical outcomes were
quantified in a rat model of facial nerve injury.
2 | MATERIALS AND METHODS
2.1 | Overview of methods
In total, 23 male Wistar Rats (250-450 g; Envigo) were used:
3 uninjured, 4 suture neurorrhaphy, 8 suture neurorrhaphy plus e.stim,
and 8 suture neurorrhaphy plus e.stim and PEG. The IACUC of
Indiana University School of Medicine approved all experimental pro-
tocols. Data were collected from 18 July 2016, through 1 April 2017.
For all procedures, 2.5% isoflurane in 98% oxygen at a rate of 1 L/min
was used for anesthesia. Nine millimeter wound clips were used to
close surgical sites and 1 mL of buprenorphine hydrochloride was
administered immediately postsurgery. All surgical procedures were
performed by a trained head and neck surgeon whom had 3 weeks of
practice surgeries prior to performing the surgeries for the study.
2.2 | Surgical groups
2.2.1 | Facial nerve axotomy and neurorrhaphy
A 1.5-cm postauricular incision was made on the animal's right side to
expose the main extratemporal trunk of the facial nerve. Once 5 to
6 mm of the main truck was exposed and freed from surrounding tis-
sue, complete transection was performed 2.5 to 3 mm distal from its
exit at the stylomastoid foramen (Figure 1). Neurorrhaphy was per-
formed using 10-0 nylon suture (AROSurgical), and care was taken to
prevent excess tension on the nerve. These measures also prevented
fraying and swelling of the nerve, preventing protrusions from the
suture site, allowing for close apposition of the epineurium.
2.2.2 | Addition of brief electrical stimulation to
neurorrhaphy
Following exposure of the facial nerve, fine wire electrodes were care-
fully hooked around the nerve 2 mm proximal to the intended
axotomy site and formed into a loop encircling the nerve. Stimulator
(Pulse generator; Tektronics AFG1022 Arbitrary Function Generator,
Tektronics & Stimulus isolator; Analog Stimulus Isolator 200, A-M
Systems) test pulses were administered to confirm correct placement
of the electrodes by visually observing facial twitches. Immediately
following neurorrhaphy, the nerve was stimulated (100 μs charge-
balanced square waves; peak-to-peak amplitude 3 V) in a continuous
20 Hz train for 30 minutes.7,22 Following stimulation, electrodes were
removed, and the surgical site closed.
F IGURE 1 Anatomy of the rat facial nerve and surgical sites.
Anatomy of the rat facial nerve. The five main branches form after the
facial nerve exits the stylomastoid foramen. Red arrowhead indicates
location of facial nerve transection and neurorrhaphy. Yellow
arrowhead indicates the site of retrograde tracer labeling. Adapted
from Hohman et al. JAMA Facial Plas Surg. 2014;16 (1):20-24.
doi:10.1001/jamafacial2013.1431
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2.2.3 | Addition of electrical stimulation and PEG
to neurorrhaphy
For repairs utilizing PEG, a 50 wt% PEG solution (33.35 kDa; Sigma
Aldrich) was prepared in sterile water immediately before surger-
ies. Prior to axotomy, test pulses were performed as previously
described to confirm the correct placement of stimulation elec-
trodes. Once confirmed, electrodes were removed, and the area
was rinsed with a calcium-free solution (Plasma-Lyte; Baxter Inter-
national, Inc.). Following transection, the area was rinsed again
with a calcium-free solution, and two drops of 1% MB (Fisher Sci-
ence) in ddH2O were applied to both ends of the axotomized
nerve. To remove residual MB and improve visibility, the area was
rinsed again with the calcium-free solution. After neurorrhaphy
PEG solution was applied to the suture site for 60 to 90 seconds.
The area was then rinsed 5 to 6 times with a calcium containing
solution (Lactated Ringer's; Hospira).23,24 Last, e.stim was then
applied as outlined in the previous section.
2.3 | Functional outcome measures
Axotomy was visually confirmed immediately postsurgery by
observing ipsilateral facial paralysis, consisting of complete loss of
vibrissae movement, posterior orientation of vibrissae, and loss of
eye blink reflex.25 Beginning 1 week postoperatively, animals
were monitored by a single blinded observer weekly for 16 weeks
to evaluate recovery of eye blink reflex and vibrissae function.
Functional recovery was scored on a 3-point scale (1 = no recov-
ery; 2 = partial recovery; 3 = complete recovery, indistinguishable
from uninjured side). Eye blink reflex was tested by delivering a
brief direct stream of air to the eye using a rubber bulb syringe.
A score of 2 was considered recovery for eye blink reflex, which
is further defined as the ability to close the eye more than half-
way owing to voluntary muscular contraction. Vibrissae function
was monitored by stabilizing animals' heads with a rodent
restraint cone (AIMS, Inc.) with the end cut, allowing the head to
emerge and the animal to whisk freely. A score of 2 was consid-
ered recovery for vibrissae functional recovery and was defined
as the ability of the vibrissae to move synchronously during
consecutive whisks.
2.4 | Retrograde tracing
Buccal branch labeling was performed 16 weeks postoperatively. A
1-cm incision was made 5 mm dorsal to the maxilla to expose the
buccal branch. Once freed from the surrounding tissue, the buccal
branch was transected, and the proximal end bathed in 2 μL of 4%
fluorogold (Fluorochrome, LLC) (Figure 1). A small piece of absorb-
able gelatin (Gelfoam; Pfizer) was placed on the proximal end of
the transected nerve to sequester fluorogold to the area.
2.5 | Tissue analysis
One week after branch labeling, animals were anesthetized using a
mixture of ketamine and xylazine hydrochloride and perfused with
phosphate-buffered saline solution followed by 4% paraformaldehyde
(PFA). The brain and brainstem were removed, postfixed in 4% PFA
for 12 hours, and transferred to 30% sucrose solution until sectioned.
The pons from each animal was cryo-sectioned at 20 μm and mounted
on microscope slides (Superfrost slides; Thermo Scientific). Five slide
sets were collected from each animal and one slide from each set was
Nissl stained to visualize the facial motor nucleus (FMN) and prevent
double counting of motoneurons. A map of the rat FMN was used to
assess myotopic organization (Figure 2A).26 The middle seven stained
sections from each animal were used for quantification. All image
processing and counting was performed by the same blinded individ-
ual using photo editing software (Photoshop CS6; Adobe). The num-
ber of motoneurons per section, number of motoneurons with buccal
branch projections, and number of motoneurons with misguided pro-
jections were quantified.
2.6 | Data analysis
The statistical program “R” was used to perform one-way analysis of
variance using the Tukey post hoc test for all behavioral and anatomi-
cal outcomes. A P value <.05 was considered statistically significant.
3 | RESULTS
3.1 | Functional outcomes
Among the 20 male rats that underwent injury, two died prior to recov-
ering from anesthesia, one from the “Suture + e.Stim” group, and one
from the “Suture + E.Stim + PEG” group. Of the 18 remaining rats, ipsi-
lateral facial paralysis was seen immediately postsurgery. Passive eyelid
movement due to retraction of the eye may be mistaken for active
orbicularis oculi-induced closure. To prevent this misinterpretation,
slow-motion video analysis was used. Once the recovery criteria for
eye blink reflex was achieved (see Section 2), blink on the injured side
remained slower than the uninjured side and was frequently accompa-
nied by incomplete eyelid opening after a blink. Visible vibrissae move-
ment typically began 2 to 3 weeks postoperatively and consisted of
uncoordinated vibrissae oscillations. Upon reaching the criteria for
whisking recovery (see Section 2), whisks remained slower and of
smaller amplitude compared to the uninjured side.
Neurorrhaphy alone resulted in a mean (SD) time to eye blink
recovery of 9.0 (2.0) weeks, and a mean (SD) time to whisking recovery
of 13.0 (1.4) weeks. The addition of e.stim to neurorrhaphy significantly
improved time to eye blink recovery 4.3 (1.2) weeks (Tables 1 and 2),
and mean time to whisking recovery 5.6 (4.5) weeks (Tables 1 and 2).
The addition of e.stim and PEG to neurorrhaphy did not significantly
554 BROWN ET AL.
improve either time to eye blink recovery 6.0 (2.3) weeks, or time to
whisking recovery 7.3 (4.5) weeks compared to neurorrhaphy alone
(Tables 1 and 2). Not all animals reached recovery by the end of the
functional assessment period. Of interest, the percentage of rats
reaching eye blink recovery (4 of 4 [100%], 5 of 7 [71.4%], and 6 of
7 [85.7%]) and whisking (3 of 4 [75%], 6 of 7 [85.7%], and 6 of
7 [85.7%]) at 16 weeks postoperative did not favor any surgical group.
(Table 1).
3.2 | Motoneuron survival
Following peripheral nerve injury, motoneuron survival in Wistar rats
is ≥75%.18,27,28 We found 86% motoneuron survival in all surgical
groups compared to uninjured controls (mean 122.3 motoneurons per
tissue section; 95% confidence interval [CI] = 117.5-127.1; P = .01).
While mean (SD) motoneuron survival in the “Suture” 117.3 (9.6)
(95% CI = 107.7-126.9; P = .00), “Suture + E.Stim” 125.2 (10.0) (95%
CI = 15.2-135.2; P = .03), and “Suture + E.Stim + PEG” 121.8 (10.1)
(95% CI = 111.8 -131.9; P = .01) groups significantly decreased com-
pared to uninjured controls 142.6 (25.2), we found no difference
F IGURE 2 Organization of the rat facial motor nucleus. A, Nissl-stained rat facial motor nucleus is subdivided into the following five main
subnuclear groups: lateral (L), dorsal (D), intermediate (I), ventromedial (VM), and medial (M). B, Overlay of motoneurons projecting to the buccal
branch (red) from an uninjured animal. C, Overlay of motoneurons projecting to the buccal branch (red) from an injured animal; yellow arrowheads
indicate motoneurons misguiding projection to the buccal branch. Scale bar = 200 μm
TABLE 1 Recovery of function
Mean number of weeks
for recovery (SD)
95% Confidence
interval SE of group mean
No. (%) of animals reaching
recovery in 16 wk
Function
Eye blink recovery
Suture (n = 4) 9.0 (2.0) 4.0-13.9 ±1.2 4 (100.0)
Suture + E.Stim (n = 7) 4.3 (1.2) * 3.1-5.6 ± 0.5 5 (71.4)
Suture + E.Stim + PEG (n = 7) 6.0 (2.3) 3.6-8.4 ±0.9 6 (85.7)
Whisking recovery
Suture (n = 4) 13.0 (1.4) 10.8-15.3 ±0.7 3 (75.0)
Suture + E.Stim (n = 7) 5.6 (4.5) * 0.1-11.2 ± 2.0 6 (85.7)
Suture + E.Stim + PEG (n = 7) 7.3 (4.5) 2.7-12.0 ± 1.8 6 (85.7)
Abbreviations: SD, standard deviation; SE, standard error; E.Stim, electrical stimulation; PEG, polyethylene glycol.
*P < .05, Tukey's post hoc compared to Suture group.
TABLE 2 Functional outcomes
Group comparisons Significance
Multiple comparisons (ANOVA and Tukey HSD)
Eye blink recovery (ANOVA; P = .03)
Suture vs Suture + E.Stim .02
Suture vs Suture + E.Stim + PEG .25
Suture + E.Stim vs Suture + E.Stim + PEG .42
Whisking recovery (ANOVA; P = .04)
Suture vs Suture + E.Stim .04
Suture vs Suture + E.Stim + PEG .11
Suture + E.Stim vs Suture + E.Stim + PEG .75
Abbreviations: ANOVA, analysis of variance; E.Stim, electrical stimulation;
PEG, polyethylene glycol.
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between the “Suture” group compared to either the “Suture + E.stim”
(95% CI = 115.2-135.2; P = .60) or “Suture + E.Stim + PEG” (95%
CI = 111.8-131.9; P = .90) groups (Figure 3A). These results indicate
that none of our surgical interventions provided benefit nor produced
adverse effects on motoneuron survival.
3.3 | Amount and specificity of regrowth
Amount of regrowth was assessed by quantifying the number of
motoneurons routing projections to the buccal branch via fluorogold
labeling at 16 weeks postoperative (Figure 2B and C). We found no
significant differences in the mean number motoneurons with buccal
branch projections between groups (95% CI = 28.4-37.1; P = .18)
(Figure 3B). These data suggest that brief electrical stimulation with
or without the addition of PEG produce no beneficial or adverse
effects on the amount of regrowth compared to neurorrhaphy alone.
Following injury, the myotopic organization of the FMN is
disrupted, contributing to facial synkinesis.29 This results from reg-
enerating axons being misguided to the incorrect nerve branch and
subsequent musculature.30 In uninjured animals, motoneurons from
the lateral, dorsal, and intermediate subnuclei project to the buccal
branch (Figure 2B). Following injury and repair, motoneurons in the
ventromedial and medial subnuclei also project to the buccal branch,
disrupting this myotopic organization (Figure 2C). Our data show a
significant disorganization in all surgical groups compared to uninjured
controls (95% CI = 9.0-17.7; P < .01) (Figure 3C). The addition of e.
stim to neurorrhaphy resulted in greater disorganization compared to
neurorrhaphy alone (95% CI = 13.6-17.1; P = .01).
It should be noted that buccal branch labeling was suboptimal in
one animal from the “Suture” group, one animal from the “Suture + E.
Stim” group, and two animals from the “Suture + E.Stim + PEG” group.
Data from these animals were not included in amount and specificity
of regrowth quantification.
F IGURE 3 F Anatomical outcomes. Blue lines indicate mean values; error bars, 95% CIs. *P < .05, **P < .01, ***P < .001. E.Stim, electrical
stimulation; PEG, polyethylene glycol
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4 | DISCUSSION
Multiple studies have shown the efficacy of e.stim to promote
recovery after peripheral nerve injury. Following sciatic nerve tran-
section 1 hour of e.stim accelerates axon regeneration, improves
specificity of regrowth, and temporally compresses “staggered
regeneration” times.7,31 Additionally, 30 minutes of e.stim follow-
ing facial nerve crush improves functional outcomes.13,14 To our
knowledge, the current study is the first to show that as little as
30 minutes of intraoperative e.stim is needed to improve functional
outcomes following transection and neurorrhaphy. The well-
characterized PEG fusion protocol used by Bittner, Ghergherehchi,
Riley, and Mikesh has improved functional and anatomical out-
comes in the sciatic nerve injury model.19,24,32,33 Bittner et al19
reports that using this protocol, even unskilled surgeons, after
some training, have a high success rate (≥98%) of PEG fusion.
However, the favorable outcomes due to PEG fusion can be
impaired by excess tension on the nerve.34-36
PEG fusion is commonly evaluated immediately following PEG
application by measuring compound action potentials (CAPs).19,32
However, there are multiple issues with immediate evaluation of
CAPs. First, axons distal to the injury do not fragment until 37 hours
after transection, still allowing for conduction of electrical current.37
Clinically this is evident as the nerve distal to the injury is identifiable
via electrical stimulation for up to 72 hours.36,38 Second, small
amounts of solution(s) in the surgical field can conduct electrical cur-
rent.38 To circumvent these issues, Salomone et al39 measured com-
pound muscle action potentials (CMAPs) following PEG fusion, and
showed no electrophysiologic differences until 6 weeks postopera-
tively. Due the limitations in-vivo with measuring CAPs immediately
following repair, and differences in CMAPs not appearing until
6 weeks post-operatively, we concur with Bittner et al17 that behav-
ioral outcomes are the best measure of success for a treatment. To
completely separate the rat facial nerve from surrounding tissue(s)
and solutions in the surgical field, excess tension would need to be
applied to the nerve, undeniably impacting regeneration and recovery.
Due to high success rate of PEG fusion, issues with measuring CAPs
immediately postrepair, and the harmful effects of applying excess
tension on the nerve, we did not measure CAPs immediately following
PEG fusion.
Despite our previous study showing PEG provided no neurologi-
cal benefits in our model of nerve injury, we hypothesized that com-
bining e.stim with PEG would further improve outcomes, due to
PEG's ability to limit injury signaling cascades, and e.stim accelerating
axonal regeneration. However, we found that this combinatorial treat-
ment hindered the functional benefits provided by e.stim alone.
Anatomically, recovery is impacted by neuronal death, impaired
regrowth, poor specificity of regeneration, and aberrant branching,
three of which were evaluated here.4 Following peripheral nerve
injury neuronal death is minimal in the rat, and we found no adverse
effects of our intraoperative treatments.6,27,28 At 16 weeks postop-
eratively the amount of regrowth was similar between uninjured
controls and all surgical groups.
Following neurorrhaphy of a mixed nerve, motoneurons preferen-
tially regrow into motor pathways if given equal access to motor and
sensory pathways via preferential motor reinnervation (PMR). PMR is
evident 8 weeks postoperatively when misguided motoneuron projec-
tions to sensory pathways are pruned, resulting in improved specific-
ity.40,41 The addition of e.stim accelerates PMR to 3 weeks after
repair.7 8 weeks after repair, when PMR has occurred, Robinson
et al16 found that PEG impaired specificity of regrowth, likely due to
non-specific PEG fusion “locking” axons in place, limiting pathway
sampling. PMR results from the specificity of trophic support from
sensory or motor specific Schwann cells.42,43 There is no know dis-
tinction between trophic support from Schwann cells in different
motor branches. Thus, the known mechanism for improved specificity
of regrowth in mixed nerves is not present in purely motor nerves,
such as the rat facial nerve. Since e.stim accelerates regrowth, and
PMR is not present in purely motor nerves, this is likely why we found
more non-specific regrowth in our e.stim group, and improved recov-
ery times.
Due to the above differences in the specificity of regrowth in
mixed-nerves verses motor nerves; we suggest clinicians evaluate the
efficacy of treatments such as e.stim and PEG on a case-by-case basis.
The evidence supporting the addition of e.stim to neurorrhaphy is
favorable in both mixed and motor nerves, however, the efficacy of
PEG is still debated. We previously found that PEG provided no bene-
fit beyond suturing alone in a motor nerve, and Robinson et al16
reported impaired specificity of regrowth in a mixed nerve when PEG
was applied. However, other groups report PEG being a potential pan-
acea. Based on our findings, intraoperative e.stim proximal seems to
hasten functional recovery, though longer-term follow-up is necessary
to determine if overall improvement is better compared to suture neu-
rorrhaphy alone.
4.1 | Limitations
For functional outcome measures, the observer was blinded; how-
ever, this approach to scoring does not remove all subjectivity.
Other studies have used more advanced opto-electric systems to
assess functional recovery, which would remove any subjectivity
from the functional evaluations used here.44,45 As previously men-
tioned in the discussion section, we did not directly assess axon
fusion via CAP measurement, which is a limitation of the current
study. Future studies using this injury model should assess axon
fusion by measuring CMAPs. Since no time course was performed
to evaluate regrowth, we cannot determine the temporal effects
our treatments. We also did not histologically evaluate the repair
site. To date, no studies using PEG have done so; thus, we cannot
confirm or deny that PEG may “lock” axons in place limiting their
ability to sample possible pathways. Last, due to anatomical con-
straints in our model, and proactively limiting tension on the nerve,
the musculature underlying the facial nerve was undoubtedly stim-
ulated during e.stim, which may contribute to improvements in
these animals.
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5 | CONCLUSION
The addition of brief, 30 minute, intraoperative e.stim to neu-
rorrhaphy in this rodent model improved functional outcomes, which
is consistent with other models of peripheral nerve injury. The addi-
tion PEG provided no further neurological benefit, and negated the
benefits e.stim provided. The encouraging improvements e.stim pro-
vided in the absence of PEG, should be corroborated by clinical trials
with long-term follow-ups. Future studies should evaluate whether e.
stim alters long-term facial synkinesis in other injury models.
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